Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care (Q35032358)

5 August 2017

Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care (English)

1 reference

patient-centered healthcare

5 August 2017

1 reference

1 reference

Anirban Basu

1

1 reference

5 August 2017

23 April 2011

1 reference

Journal of Health Economics

5 August 2017

1 reference

5 August 2017

30

1 reference

5 August 2017

3

1 reference

5 August 2017

549-559

1 reference

The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Does comparative-effectiveness research threaten personalized medicine?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Health spending projections through 2018: recession effects add uncertainty to the outlook

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Social costs of robbery and the cost-effectiveness of substance abuse treatment.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Value of information on preference heterogeneity and individualized care

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

An experimental design for the development of adaptive treatment strategies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

A national 5-year follow-up of treatment outcomes for cocaine dependence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Nonresponse and selection bias in treatment follow-up studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Local instrumental variables and latent variable models for identifying and bounding treatment effects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Health insurance: the tradeoff between risk pooling and moral hazard

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Evaluating the effectiveness of addiction treatments: reasonable expectations, appropriate comparisons

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Comment on "nonresponse and selection bias in treatment follow-up studies".

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Mathematical programming for the efficient allocation of health care resources.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110511

Benign moral hazard and the cost-effectiveness analysis of insurance coverage

25 October 2018

1 reference

12 December 2020

Third party purchasing of health services: patient choice and agency

1 reference

12 December 2020

Value-based insurance design

1 reference

12 December 2020

Subgroups and heterogeneity in cost-effectiveness analysis

1 reference

12 December 2020

Moral hazard in insurance, value-based cost sharing, and the benefits of blissful ignorance

1 reference

12 December 2020

Individualization at the heart of comparative effectiveness research: the time for i-CER has come

1 reference

12 December 2020

A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost

1 reference

12 December 2020

10.1016/J.JHEALECO.2011.03.004

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

PubMed ID

21601299